par El Khoury, G;Darcis, Gilles;Lee, Sophie;Bouchat, Benoît 
;Van Driessche, Damian ;Purcell, Carine;Van Lint,
Référence Advances in experimental medicine and biology, 1075, page (187-212)
Publication Publié, 2018
;Van Driessche, Damian ;Purcell, Carine;Van Lint, Référence Advances in experimental medicine and biology, 1075, page (187-212)
Publication Publié, 2018
Article révisé par les pairs
| Résumé : | HIV remains incurable due to the existence of a reservoir of cells that harbor intact integrated genomes of the virus in the absence of viral replication. This population of infected cells remains invisible to the immune system and is not targeted by the drugs used in the current antiretroviral therapies (cART). Reversal of latency by the use of inhibitors of chromatin-remodeling enzymes has been studied extensively in an attempt to purge this reservoir of latent HIV but has thus far not shown any success in clinical trials. The full complexity of latent HIV infection has still not been appreciated, and the gaps in knowledge prevent development of adequate small-molecule compounds that can effectively perturb this reservoir. In this review, we will examine the role of epigenetic silencing of HIV transcription, posttranscriptional regulation, and mRNA processing in promoting HIV-1 latency. |
